Capital International Investors Abbott Laboratories Transaction History

Capital International Investors

$483 Billion
Q1 2024

A detailed history of Capital International Investors transactions in Abbott Laboratories stock. As of the latest transaction made, Capital International Investors holds 70,177,564 shares of ABT stock, worth $7.17 Billion. This represents 1.65% of its overall portfolio holdings.

Number of Shares

70,177,564

Previous 64,294,784 9.15%

Holding current value

$7.17 Billion

Previous $7.08 Billion 12.71%

% of portfolio

1.65%

Previous 1.62%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $644 Million - $712 Million	5,882,780 Added 9.15%	70,177,564 $7.98 Billion
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $131 Million - $161 Million	1,457,847 Added 2.32%	64,294,784 $7.08 Billion
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $349 Million - $419 Million	3,658,330 Added 6.18%	62,836,937 $6.09 Billion
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $277 Million - $309 Million	2,747,652 Added 4.87%	59,178,607 $6.45 Billion
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $330 Million - $388 Million	3,405,170 Added 6.42%	56,430,955 $5.71 Billion

Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $75.4 Million - $88.5 Million	793,409 Added 1.52%	53,025,785 $5.82 Billion
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $166 Million - $192 Million	1,711,790 Added 3.39%	52,232,376 $5.05 Billion
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $28 Million - $33.9 Million	274,568 Added 0.55%	50,520,586 $5.49 Billion
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $245 Million - $299 Million	-2,151,653 Reduced 4.11%	50,246,018 $5.95 Billion
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $530 Million - $649 Million	-4,591,062 Reduced 8.06%	52,397,671 $7.37 Billion
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $119 Million - $132 Million	1,020,391 Added 1.82%	56,988,733 $6.73 Billion
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $149 Million - $175 Million	1,408,600 Added 2.58%	55,968,342 $6.49 Billion
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $105 Million - $124 Million	968,271 Added 1.81%	54,559,742 $6.54 Billion
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $251 Million - $273 Million	-2,386,176 Reduced 4.26%	53,591,471 $5.87 Billion
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $67.5 Million - $82 Million	-736,423 Reduced 1.3%	55,977,647 $6.09 Billion
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $71.4 Million - $91.4 Million	932,527 Added 1.67%	56,714,070 $5.18 Billion
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $531 Million - $777 Million	8,454,341 Added 17.86%	55,781,543 $4.4 Billion
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $104 Million - $116 Million	1,328,056 Added 2.89%	47,327,202 $4.11 Billion
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $649 Million - $703 Million	7,927,194 Added 20.82%	45,999,146 $3.85 Billion
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $992 Million - $1.16 Billion	13,618,062 Added 55.69%	38,071,952 $3.2 Billion
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $117 Million - $142 Million	1,773,904 Added 7.82%	24,453,890 $1.95 Billion
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $184 Million - $209 Million	2,810,299 Added 14.14%	22,679,986 $1.64 Billion
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $870 Million - $1.05 Billion	14,303,610 Added 256.98%	19,869,687 $1.46 Billion
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $389,576 - $429,975	6,767 Added 0.12%	5,566,077 $339 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $199 Million - $225 Million	3,535,510 Added 174.7%	5,559,310 $333 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $97.3 Million - $109 Million	2,023,800	2,023,800 $108 Million

Others Institutions Holding ABT

# of Institutions

3,124

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Abbott Laboratories Transaction History